Mitoxantrone Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 2 mg/mL
Reference Brands: Novantrone (USA)
Category:
Oncology Cancer Care
Mitoxantrone (brand name Novantrone® and generics) is an antineoplastic (chemotherapy) medication used to treat certain cancers like acute nonlymphocytic leukemia (ANLL), advanced prostate cancer, and selected multiple sclerosis (MS) cases by slowing down abnormal cell growth and suppressing an overactive immune system. It is delivered as an intravenous infusion in a clinical setting.
Mitoxantrone is available in Injection
and strengths such as 2 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Mitoxantrone is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Mitoxantrone can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Mitoxantrone hydrochloride is an antineoplastic chemotherapy medication widely used in Oncology Cancer Care for treating various malignant conditions. It is most commonly prescribed for acute non-lymphocytic leukemia, advanced hormone-refractory prostate cancer, and selected severe cases of multiple sclerosis where other therapies have not been effective. Mitoxantrone works by binding to DNA and inhibiting topoisomerase II, an essential enzyme involved in DNA replication and repair. This action disrupts the growth and division of rapidly multiplying cancer cells, ultimately leading to their destruction. The drug is administered strictly by intravenous infusion under medical supervision, ensuring controlled dosing and monitoring for potential side effects. In oncology settings, mitoxantrone is often used in combination with other chemotherapeutic agents to increase treatment effectiveness. It is known for its deep blue coloration and is typically supplied as a 2 mg/mL injection solution in single-dose or multi-dose vials. While effective, mitoxantrone requires careful monitoring due to the risk of cardiotoxicity, bone marrow suppression, and cumulative dose limitations. Despite these considerations, it remains an important treatment option in modern cancer therapy and is widely used in many global treatment protocols.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing